Pressure Biosciences' Q1 Revenues Dip | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure Biosciences reported after the close of the market Monday that its first-quarter revenues dipped 5 percent, which the firm said was due to two mid-Atlantic snowstorms in February.

The South Easton, Mass.-based firm reported total revenues of $290,813 for the three-month period ended March 31, compared to $306,762 for the first quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.